Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at TKT will continue without interruption and with the same staff, in the same facilities in … Continue reading CTR acquires preclinical toxicology company
CTR tillkännager att styrelsen har utsett Karin Meyer till ny verkställande direktör. Karin Meyer efterträder Mats Lindquist som varit verkställande direktör sedan starten av CTR 2016. Karin Meyer har en lång erfarenhet av ledande befattningar inom läkemedels- och biotechindustrin, god branschkännedom och en mycket god förståelse för utveckling av nya produkter inom dessa områden. Karin, … Continue reading Karin Meyer blir ny VD för Center for Translational Research Sweden AB (CTR)
ClinSmart and its sister company Clinical Trial Consultants (CTC) participate in a pilot project for virtual studies initiated by the Medical Products Agency in Sweden. Within the framework of the project, certain assessments normally performed at a clinical research unit will be replaced by virtual equivalents in one of the trials conducted at CTC. In … Continue reading Start-up of virtual study in a pioneering pilot project
From July 1, ClinSmart comprises facilities in Uppsala, one floor above the clinics for the sister company Clinical Trial Consultants. The new research unit on the fourth floor of Oscar II in Uppsala Science Park, will be renovated during the summer and will be kick starting the business properly in September. “We look forward to … Continue reading ClinSmart are moving in!
The corporate group is growing when the holding company Center for Translational Research Sweden (CTR) is staring an additional company, ClinSmart Sweden. The company will have a strong focus on digital solutions and will, together with Clinical Trial Consultants (CTC), conduct clinical trials in phase II and forward. CTC’s existing full-service offer for early phase clinical … Continue reading Focus on phase II trials